[Form 4/A] CONMED Corp Amended Insider Trading Activity
Filing Impact
Filing Sentiment
Form Type
4/A
Rhea-AI Filing Summary
SHAGORY PETER K reported acquisition or exercise transactions in this Form 4 filing.
CONMED Corporation executive Peter K. Shagory received a corrected equity award totaling 16,926 restricted stock units (RSUs). Each RSU represents a right to receive one share of CONMED common stock under the Company’s 2025 Long-Term Incentive Plan.
The RSUs generally vest over three years, with 33% vesting one year after the grant date, another 33% in the second year, and 34% in the third year. This Form 4/A amends the prior report to reflect that a special award of 7,644 RSUs was granted in addition to the originally reported 9,282 RSUs, for the total 16,926 RSUs now shown as held directly following the transaction.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
SHAGORY PETER K
Role
EVP, STRAT & CORP DEVT
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | RSUs (Restricted Stock Units) | 16,926 | $0.00 | -- |
Holdings After Transaction:
RSUs (Restricted Stock Units) — 16,926 shares (Direct)
Footnotes (1)
- Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of CONMED Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2025 Long-Term Incentive Plan, with the RSUs generally vesting over a three-year period with the first 33% of the RSUs vesting one year after the grant date, 33% second year and 34% third year. This Form 4/A is filed solely to correct the amount of RSUs granted. A special award of 7,644 shares was awarded in addition to the originally reported 9,282 shares for a total of 16,926 RSUs granted.